General Resources / Legal Resources / Medical
Resources / Briefing Papers / State Activity
Hospital Closures / Preventable
Tragedies / Press Room / Search
Our Site / Home
Further Parameters
of Insight and Neuropsychological Deficit in Schizophrenia and Other Chronic Mental
Disease.
Young DA; Zakzanis, KK; Baily C;. Davila R; Griese J;
Sartory G & Thom A.
Journal of Nervous and Mental Disease, 186,
44-50. 1998.
Summarized by Dr. Xavier Amador
RELEVANCE FOR EARLY INTERVENTION
This recent study of 108 patients with schizophrenia,
found, once again, strong correlations between various tests of frontal lobe function and
level of insight. Using the Scale to assess Unawareness of Mental Disorder (SUMD), Young
and his colleagues found significant correlations between percent of perseverative errors
on the Wisconsin Card Sort Test and overall awareness of illness and attributions for
specific symptoms as measured by the SUMD. In this study bipolar patients were also
examined using the same methodology, however no significant associations between the
insight measure and tests of frontal lobe performance were found. These results replicate
previous findings that support the idea that poor insight into illness and resulting
treatment refusal stem from a mental defect rather than informed choice in patients with
schizophrenia.
General Resources / Legal Resources / Medical
Resources / Briefing Papers / State Activity
Hospital Closures / Preventable
Tragedies / Press Room / Search
Our Site / Home
Treatment Advocacy
Center
|
The contents
of all material available on the Center's website are copyrighted by the Treatment
Advocacy Center unless otherwise indicated. All rights reserved and content may be
reproduced, downloaded, disseminated, or transferred, for single use, or by nonprofit
organizations for educational purposes only, if correct attribution is made to the
Treatment Advocacy Center. Please feel free to call with questions on mental
illness, treatment laws or the benefits of medication compliance at 703.294.6001 or send
questions via email to [email protected].
Write to us at: The Treatment Advocacy Center; 3300 N. Fairfax Drive; Suite
220; Arlington, VA 22201. Technical comments on the Center's website
(www.psychlaws.org) can be sent to [email protected].
The Treatment Advocacy Center is an I.R.C. � 501(c)(3) tax-exempt corporation.
Donations are appreciated and are eligible for the charitable contribution deduction under
the provisions of I.R.C. � 170. |